Advertisement

Topics

Cardiome Pharma Crop. Company Profile

07:47 EDT 24th September 2018 | BioPortfolio

Cardiome Pharma Corp.is a product-focused cardiovascular drug developmentCompany with two clinical drug programs focused on atrual arrhythmia,and a pre-clinical
program directed at improving cardiovascular function
cardiome is traded on the Toronto Stock Exchange (COM) and the NASDAQ national Market(CRME)

Location

6790 Agronomy Rd.,6 th Floor
Vancouver
British Columbia
V6T 1Z3
Canada

Contact

Phone: 1-604-677-6905
Fax: 1-604-677-6915
Email: dgraham@cardiome.com


News Articles [842 Associated News Articles listed on BioPortfolio]

Cardiome Announces Amendment to Term Loan Agreement with CRG-Managed Funds

About Cardiome Pharma Corp. Cardiome Pharma Corp. is a revenue-generating, specialty pharmaceutical company focused on providing innovative, high-quality brands that meet the needs of acute Read ...

Cardiome Pharma Corp (COM) Insider Sheila Grant Sells 7,943 Shares

Cardiome Pharma Corp insider Sheila Grant sold 7,943 shares of Cardiome Pharma stock in a transaction on Wednesday, March 28th. The shares were sold at an average price of C$2.26, for a total transact...

Cipher to buy Cardiome Pharma's Canadian business portfolio

Cipher Pharmaceuticals has entered into a definitive arrangement agreement to acquire the Canadian business portfolio of Cardiome Pharma.

Active-Investors: Blog Exposure - Cipher to Acquire Cardiome's Canadian Business Portfolio for $25.5 Million in Cash

Stock Monitor: Apricus Biosciences Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 22, 2018 / Active-Investors.com has just released a free research report on Cardiome Pharma Corp. (NASDAQ:...

Ciper pays $Cdn25.5mm for Cardiome's Canadian business portfolio

Cipher Pharmaceuticals Inc. is paying $Cdn25.5mm ($19.5mm) to acquire Cardiome Pharma Corp.'s Canadian business portfolio. Cipher will finance the transaction with cash and new debt.

Cipher pays $Cdn25.5mm for Cardiome's Canadian business portfolio

Cipher Pharmaceuticals Inc. is paying $Cdn25.5mm ($19.5mm) to acquire Cardiome Pharma Corp.'s Canadian business portfolio. Cipher will finance the transaction with cash and new debt.

Cardiome Pharma's (CRME) CEO Bill Hunter on Q4 2017 Results - Earnings Call Transcript

Cardiome Pharma's (CRME) CEO William Hunter on Q1 2018 Results - Earnings Call Transcript

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [278 Associated PubMed Articles listed on BioPortfolio]

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Multiple-Disease System in Coffee: From Crop Loss Assessment to Sustainable Management.

Assessment of crop loss due to multiple diseases and pests (D&P) is a necessary step in designing sustainable crop management systems. Understanding the drivers of D&P development and yield loss helps...

Clinical trials go virtual, big pharma dives in.

Isoline use in crop composition studies with genetically modified crops under EFSA guidance - Short communication.

The European Food Safety Authority (EFSA) oversees the safety evaluation of genetically modified (GM) crops in the European Union. EFSA requires inclusion of commercial non-GM reference lines and a no...

Effects of plastic mulching and plastic residue on agricultural production: A meta-analysis.

China is a large agricultural country, and food security is significantly limited by the shortage of water resources. Plastic mulching technology can effectively modify the crop growth environment and...

Clinical Trials [92 Associated Clinical Trials listed on BioPortfolio]

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition

The primary objective is to determine clinical bioequivalence of Amphotericin B liposome for injection of Auromedics Pharma LLC, USA and AmBisome (Amphotericin B) liposome for injection of...

Companies [850 Associated Companies listed on BioPortfolio]

Cardiome Pharma Crop.

Cardiome Pharma Corp.is a product-focused cardiovascular drug developmentCompany with two clinical drug programs focused on atrual arrhythmia,and a pre-clinicalprogram directed at improving cardiovasc...

Cardiome Pharma

Cardiome Pharma Corp is a drug development company focused on proprietary drugs to treat or prevent cardiac diseases. Cardiome's drug development efforts target the treatment of cardiac arrhythmia (ir...

Cardiome Pharma Corp.

Merck and Cardiome Pharma Corp.

In April 2009, Cardiome and Merck announced a collaboration and license agreement for the development and commercialization of vernakalant. The agreement provides Merck, Sharp and...

Mycogen Corporation

Mycogen Corporation, is a diversified agribusiness and biotechnology company that develops and markets seed for improved crop varieties and provides crop protection products and services. The Company...

More Information about "Cardiome Pharma Crop." on BioPortfolio

We have published hundreds of Cardiome Pharma Crop. news stories on BioPortfolio along with dozens of Cardiome Pharma Crop. Clinical Trials and PubMed Articles about Cardiome Pharma Crop. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cardiome Pharma Crop. Companies in our database. You can also find out about relevant Cardiome Pharma Crop. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record